NXT1, a novel influenza A NP binding protein, promotes the nuclear export of NP via a CRM1-dependent pathway

Viruses

Volumn 8, Issue 8, 2016, Pages

  Chutiwitoonchai, Nopporn ^a   Aida, Yoko ^a  

^a RIKEN   (Japan)

Author keywords

CRM1; Influenza A virus; NP; Nuclear export; NXT1

Indexed keywords

EXPORTIN 1; NUCLEAR TRANSPORT FACTOR 2 LIKE EXPORT PROTEIN 1; NUCLEOPORIN 153; NUCLEOPORIN 62; NUCLEOPORIN 98; NUCLEOPROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS RNA; CELL RECEPTOR; CORE PROTEIN; EXPORTIN 1 PROTEIN; KARYOPHERIN; NP PROTEIN, INFLUENZA A VIRUS; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; NXT1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ANIMAL CELL; ARTICLE; ASSAY; CARBOXY TERMINAL SEQUENCE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INFLUENZA A; INFLUENZA A VIRUS; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PULL DOWN ASSAY; SIGNAL TRANSDUCTION; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; CELL LINE; DOG; HOST PATHOGEN INTERACTION; INFLUENZA A VIRUS (H1N1); METABOLISM; NUCLEOCYTOPLASMIC TRANSPORT; PHYSIOLOGY; VIRUS ASSEMBLY; VIRUS RELEASE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; DOGS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; KARYOPHERINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84980340170     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8080209     Document Type: Article

References (45)

1. Johnson, N.P.; Mueller, J. Updating the accounts: Global mortality of the 1918-1920 “Spanish” influenza pandemic. Bull. Hist. Med. 2002, 76, 105-115. [CrossRef] [PubMed]
2. Dawood, F.S.; Iuliano, A.D.; Reed, C.; Meltzer, M.I.; Shay, D.K.; Cheng, P.Y.; Bandaranayake, D.; Breiman, R.F.; Brooks, W.A.; Buchy, P., et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza a H1N1 virus circulation: A modelling study. Lancet Infect. Dis. 2012, 12, 687-695. [CrossRef]
3. Gao, R.; Cao, B.; Hu, Y.; Feng, Z.; Wang, D.; Hu, W.; Chen, J.; Jie, Z.; Qiu, H.; Xu, K., et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 2013, 368, 1888-1897. [CrossRef] [PubMed]
4. Gubareva, L.V.; Fry, A.M. Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses. J. Infect. Dis. 2010, 201, 656-658. [CrossRef] [PubMed]
5. Hatakeyama, S.; Sugaya, N.; Ito, M.; Yamazaki, M.; Ichikawa, M.; Kimura, K.; Kiso, M.; Shimizu, H.; Kawakami, C.; Koike, K. et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 2007, 297, 1435-1442. [CrossRef] [PubMed]
6. Kiso, M.; Mitamura, K.; Sakai-Tagawa, Y.; Shiraishi, K.; Kawakami, C.; Kimura, K.; Hayden, F.G.; Sugaya, N.; Kawaoka, Y. Resistant influenza A viruses in children treated with oseltamivir: Descriptive study. Lancet 2004, 364, 759-765. [CrossRef]
7. Stephenson, I.; Democratis, J.; Lackenby, A.; McNally, T.; Smith, J.; Pareek, M.; Ellis, J.; Bermingham, A.; Nicholson, K.; Zambon, M. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin. Infect. Dis. 2009, 48, 389-396. [CrossRef] [PubMed]
8. Aida, Y.; Sasaki, Y.; Hagiwara, K. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein. In Antiviral Drugs—Aspects of Clinical Use and Recent Advances; Arbuthnot, P., Ed.; InTech.: Rijeka, Croatia, 2012; pp. 99-120.
9. Cianci, C.; Gerritz, S.W.; Deminie, C.; Krystal, M. Influenza nucleoprotein: Promising target for antiviral chemotherapy. Antivir. Chem. Chemother. 2013, 23, 77-91. [CrossRef] [PubMed]
10. Portela, A.; Digard, P. The influenza virus nucleoprotein: A multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 2002, 83, 723-734. [CrossRef] [PubMed]
11. Hagiwara, K.; Kondoh, Y.; Ueda, A.; Yamada, K.; Goto, H.; Watanabe, T.; Nakata, T.; Osada, H.; Aida, Y. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays. Biochem. Biophys. Res. Commun. 2010, 394, 721-727. [CrossRef] [PubMed]
12. Gerritz, S.W.; Cianci, C.; Kim, S.; Pearce, B.C.; Deminie, C.; Discotto, L.; McAuliffe, B.; Minassian, B.F.; Shi, S.; Zhu, S., et al. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc. Natl. Acad. Sci. USA 2011, 108, 15366-15371. [CrossRef] [PubMed]
13. Kao, R.Y.; Yang, D.; Lau, L.S.; Tsui, W.H.; Hu, L.; Dai, J.; Chan, M.P.; Chan, C.M.; Wang, P.; Zheng, B.J., et al. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 2010, 28, 600-605. [CrossRef] [PubMed]
14. Chutiwitoonchai, N.; Kakisaka, M.; Yamada, K.; Aida, Y. Comparative analysis of seven viral nuclear export signals (NESs) reveals the crucial role of nuclear export mediated by the third NES consensus sequence of nucleoprotein (NP) in influenza A virus replication. PLoS ONE 2014, 9, e105081. [CrossRef] [PubMed]
15. Kakisaka, M.; Mano, T.; Aida, Y. A high-throughput screening system targeting the nuclear export pathway via the third nuclear export signal of influenza A virus nucleoprotein. Virus Res. 2016, 217, 23-31. [CrossRef] [PubMed]
16. Kakisaka, M.; Sasaki, Y.; Yamada, K.; Kondoh, Y.; Hikono, H.; Osada, H.; Tomii, K.; Saito, T.; Aida, Y. A novel antiviral target structure involved in the RNA binding, dimerization, and nuclear export functions of the influenza A virus nucleoprotein. PLoS Pathog. 2015, 11, e1005062. [CrossRef] [PubMed]
17. Akarsu, H.; Burmeister, W.P.; Petosa, C.; Petit, I.; Muller, C.W.; Ruigrok, R.W.; Baudin, F. Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J. 2003, 22, 4646-4655. [CrossRef] [PubMed]
18. O’Neill, R.E.; Talon, J.; Palese, P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 1998, 17, 288-296. [CrossRef] [PubMed]
19. Brunotte, L.; Flies, J.; Bolte, H.; Reuther, P.; Vreede, F.; Schwemmle, M. The nuclear export protein of H5N1 influenza a viruses recruits matrix 1 (M1) protein to the viral ribonucleoprotein to mediate nuclear export. J. Biol. Chem. 2014, 289, 20067-20077. [CrossRef] [PubMed]
20. Kudo, N.; Matsumori, N.; Taoka, H.; Fujiwara, D.; Schreiner, E.P.; Wolff, B.; Yoshida, M.; Horinouchi, S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. USA 1999, 96, 9112-9117. [CrossRef] [PubMed]
21. Watanabe, K.; Takizawa, N.; Katoh, M.; Hoshida, K.; Kobayashi, N.; Nagata, K. Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Res. 2001, 77, 31-42. [CrossRef]
22. Perwitasari, O.; Johnson, S.; Yan, X.; Howerth, E.; Shacham, S.; Landesman, Y.; Baloglu, E.; McCauley, D.; Tamir, S.; Tompkins, S.M., et al. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza A virus replication in vitro and in vivo. J. Virol. 2014, 88, 10228-10243. [CrossRef] [PubMed]
23. Watanabe, K.; Fuse, T.; Asano, I.; Tsukahara, F.; Maru, Y.; Nagata, K.; Kitazato, K.; Kobayashi, N. Identification of Hsc70 as an influenza virus matrix protein (M1) binding factor involved in the virus life cycle. FEBS Lett. 2006, 580, 5785-5790. [CrossRef] [PubMed]
24. Watanabe, K.; Shimizu, T.; Noda, S.; Tsukahara, F.; Maru, Y.; Kobayashi, N. Nuclear export of the influenza virus ribonucleoprotein complex: Interaction of Hsc70 with viral proteins M1 and NS2. FEBS Open Bio 2014, 4, 683-688. [CrossRef] [PubMed]
25. Hu, Y.; Liu, X.; Zhang, A.; Zhou, H.; Liu, Z.; Chen, H.; Jin, M. CHD3 facilitates vRNP nuclear export by interacting with NES1 of influenza A virus NS2. Cell. Mol. Life Sci. 2015, 72, 971-982. [CrossRef] [PubMed]
26. Morita, M.; Kuba, K.; Ichikawa, A.; Nakayama, M.; Katahira, J.; Iwamoto, R.; Watanebe, T.; Sakabe, S.; Daidoji, T.; Nakamura, S., et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 2013, 153, 112-125. [CrossRef] [PubMed]
27. Munier, S.; Rolland, T.; Diot, C.; Jacob, Y.; Naffakh, N. Exploration of binary virus-host interactions using an infectious protein complementation assay. Mol. Cell. Proteom. 2013, 12, 2845-2855. [CrossRef] [PubMed]
28. Chen, J.; Huang, S.; Chen, Z. Human cellular protein nucleoporin hNup98 interacts with influenza A virus NS2/nuclear export protein and overexpression of its GLFG repeat domain can inhibit virus propagation. J. Gen. Virol. 2010, 91, 2474-2484. [CrossRef] [PubMed]
29. Satterly, N.; Tsai, P.L.; van Deursen, J.; Nussenzveig, D.R.; Wang, Y.; Faria, P.A.; Levay, A.; Levy, D.E.; Fontoura, B.M. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. USA 2007, 104, 1853-1858. [CrossRef] [PubMed]
30. Neumann, G.; Watanabe, T.; Ito, H.; Watanabe, S.; Goto, H.; Gao, P.; Hughes, M.; Perez, D.R.; Donis, R.; Hoffmann, E., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 1999, 96, 9345-9350. [CrossRef] [PubMed]
31. Hagiwara, K.; Murakami, T.; Xue, G.; Shimizu, Y.; Takeda, E.; Hashimoto, Y.; Honda, K.; Kondoh, Y.; Osada, H.; Tsunetsugu-Yokota, Y., et al. Identification of a novel Vpr-binding compound that inhibits HIV-1 multiplication in macrophages by chemical array. Biochem. Biophys. Res. Commun. 2010, 403, 40-45. [CrossRef] [PubMed]
32. Chou, Y.Y.; Heaton, N.S.; Gao, Q.; Palese, P.; Singer, R.H.; Lionnet, T. Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog. 2013, 9, e1003358. [CrossRef]
33. Sasaki, Y.; Kakisaka, M.; Chutiwitoonchai, N.; Tajima, S.; Hikono, H.; Saito, T.; Aida, Y. Identification of a novel multiple kinase inhibitor with potent antiviral activity against influenza virus by reducing viral polymerase activity. Biochem. Biophys. Res. Commun. 2014, 450, 49-54. [CrossRef] [PubMed]
34. Hao, L.; Sakurai, A.; Watanabe, T.; Sorensen, E.; Nidom, C.A.; Newton, M.A.; Ahlquist, P.; Kawaoka, Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454, 890-893. [CrossRef] [PubMed]
35. Braun, I.C.; Herold, A.; Rode, M.; Conti, E.; Izaurralde, E. Overexpression of TAP/p15 heterodimers bypasses nuclear retention and stimulates nuclear mRNA export. J. Biol. Chem. 2001, 276, 20536-20543. [CrossRef] [PubMed]
36. Levesque, L.; Guzik, B.; Guan, T.; Coyle, J.; Black, B.E.; Rekosh, D.; Hammarskjold, M.L.; Paschal, B.M. RNA export mediated by TAP involves NXT1-dependent interactions with the nuclear pore complex. J. Biol. Chem. 2001, 276, 44953-44962. [CrossRef] [PubMed]
37. Wiegand, H.L.; Coburn, G.A.; Zeng, Y.; Kang, Y.; Bogerd, H.P.; Cullen, B.R. Formation of TAP/NXT1 heterodimers activates TAP-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Mol. Cell. Biol. 2002, 22, 245-256. [CrossRef] [PubMed]
38. Ossareh-Nazari, B.; Maison, C.; Black, B.E.; Levesque, L.; Paschal, B.M.; Dargemont, C. RanGTP-binding protein NXT1 facilitates nuclear export of different classes of RNA in vitro. Mol. Cell. Biol. 2000, 20, 4562-4571. [CrossRef] [PubMed]
39. Black, B.E.; Holaska, J.M.; Levesque, L.; Ossareh-Nazari, B.; Gwizdek, C.; Dargemont, C.; Paschal, B.M. NXT1 is necessary for the terminal step of CRM1-mediated nuclear export. J. Cell Biol. 2001, 152, 141-155. [CrossRef] [PubMed]
40. Yu, M.; Liu, X.; Cao, S.; Zhao, Z.; Zhang, K.; Xie, Q.; Chen, C.; Gao, S.; Bi, Y.; Sun, L., et al. Identification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein. J. Virol. 2012, 86, 4970-4980. [CrossRef] [PubMed]
41. Black, B.E.; Levesque, L.; Holaska, J.M.; Wood, T.C.; Paschal, B.M. Identification of an NTF2-related factor that binds Ran-GTP and regulates nuclear protein export. Mol. Cell. Biol. 1999, 19, 8616-8624. [CrossRef] [PubMed]
42. Katahira, J.; Strasser, K.; Podtelejnikov, A.; Mann, M.; Jung, J.U.; Hurt, E. The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to human. EMBO J. 1999, 18, 2593-2609. [CrossRef] [PubMed]
43. Guzik, B.W.; Levesque, L.; Prasad, S.; Bor, Y.C.; Black, B.E.; Paschal, B.M.; Rekosh, D.; Hammarskjold, M.L. NXT1 (p15) is a crucial cellular cofactor in TAP-dependent export of intron-containing RNA in mammalian cells. Mol. Cell. Biol. 2001, 21, 2545-2554. [CrossRef] [PubMed]
44. Elton, D.; Simpson-Holley, M.; Archer, K.; Medcalf, L.; Hallam, R.; McCauley, J.; Digard, P. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J. Virol. 2001, 75, 408-419. [CrossRef] [PubMed]
45. Read, E.K.; Digard, P. Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export. J. Gen. Virol. 2010, 91, 1290-1301. [CrossRef] [PubMed]